Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,646 people get AGN articles and Market Currents by email alert.
Get email alerts on AGN »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Apr 3, 2013)
To learn more about Seeking Alpha Pro, click here.
-
Allergan: Earnings PreviewZacks Investment Research • Tue, May 1, 2012
-
Earnings Preview: AllerganTheflyonthewall • Wed, Feb 1, 2012
-
Allergan Beats, Revises GuidanceZacks Investment Research • Wed, Aug 3, 2011
-
Allergan: Too Late to Jump In?Derastone • Mon, Aug 9, 2010
-
Put Sellers Bet Allergan Will Hold FirmoptionMONSTER • Mon, Aug 2, 2010
-
Allergan Attracts Bearish PositionoptionMONSTER • Mon, May 3, 2010
-
Earnings Preview: AllerganTheflyonthewall • Thu, Apr 29, 2010
-
Allergan Gets FDA Approval: Botox Has a Medical Use?Ockham Research • Wed, Mar 10, 2010
-
Allergan Management Discusses Q3 2012 Results - Earnings Call TranscriptTue, Oct 30, 2012
-
Allergan Management Discusses Q3 2011 Results - Earnings Call TranscriptWed, Oct 26, 2011 • 2 Comments
-
Allergan's CEO Discusses Q1 2011 Results - Earnings Call TranscriptThu, May 5, 2011
-
Allergan's CEO Discusses Q4 2010 Results - Earnings Call TranscriptWed, Feb 2, 2011
-
Allergan CEO Discusses Q3 2010 Results - Earnings Call TranscriptMon, Nov 1, 2010
-
Allergan Q2 2010 Earnings Call TranscriptMon, Aug 2, 2010
-
Allergan Q1 2010 Earnings Call TranscriptFri, Apr 30, 2010
-
Allergan, Inc. Q4 2009 Earnings Call TranscriptThu, Feb 4, 2010
-
Allergan Q3 2009 Earnings Call TranscriptThu, Oct 29, 2009
-
Allergan Inc. Q2 2009 Earnings Call TranscriptFri, Jul 31, 2009
-
Allergan Inc. Q1 2009 Earnings Call TranscriptFri, May 1, 2009
-
Allergan Q4 2008 Earnings Call TranscriptWed, Feb 4, 2009
-
Allergan Inc. F3Q08 (Qtr End 9/30/08) Earnings Call TranscriptWed, Oct 29, 2008
-
at CNBC.com (May 2, 2013)
-
at CNBC.com (May 1, 2013)
-
at MarketWatch.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
Business Wire (May 1, 2013)
-
at CNBC.com (Apr 30, 2013)
-
Business Wire (Apr 30, 2013)
-
at CNBC.com (Apr 26, 2013)
-
Business Wire (Apr 3, 2013)
-
at CNBC.com (Mar 26, 2013)
-
Business Wire (Feb 20, 2013)
-
at CNBC.com (Feb 6, 2013)
-
at CNBC.com (Feb 5, 2013)
-
at MarketWatch.com (Feb 5, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Jan 31, 2013)
-
at Fox Business (Jan 23, 2013)
AGN vs. ETF Alternatives
Company Description
We are a multi-specialty health care company focused on developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential — to see more clearly, move more freely and express themselves more fully. Our diversified... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, October 30, 2012, 12:12 PM In its conference call, Allergan (AGN) says it's exploring strategic options for its obesity intervention business,including a potential sale of the business unit. If it does pursue that option however, the company adds that it intends to offset any potential earnings dilution related to the transaction. Comment! [Healthcare, M&A]
- Tuesday, October 30, 2012, 10:12 AM More on Allergan (AGN) Q3: net profit almost flat at $249.4M. Specialty pharmaceuticals sales +8.1%, medical devices -4%. Exploring options for obesity intervention business, including selling it. Guidance: Q4 EPS of $1.18-$1.20 vs consensus of $1.20, revenue of $1.47B-$1.545B vs $1.51B; FY EPS of $4.17-$4.19 vs $4.17 and revenue of $5.695B-$5.77B and $5.82B. (PR) Comment! [Earnings, Healthcare]
- Tuesday, October 30, 2012, 9:38 AM Allergan (AGN) declares $0.05/share quarterly dividend, in line with previous. Forward yield 0.22%. For shareholders of record Nov 21. Payable Dec 12. Ex-div date Nov 19. (PR) Comment! [Dividends]
- Tuesday, October 30, 2012, 9:10 AM Allergan (AGN): Q3 EPS of $1.06 beats by $0.02. Revenue of $1.41B (+6.4% Y/Y). (PR) Comment! [Earnings, Healthcare]
- Tuesday, October 30, 2012, 12:05 AM Notable earnings scheduled for Tuesday morning: ADM, AGCO, AGN, ALLT, AMTD, ASH, BP, CAH, CBB, CIE, CMI, DB, DLPH, ECL, F, GOV, HCP, HE, IPGP, IPXL, JCI, LLL, MCGC, MPW, NUS, PCS, PNR, SWC, TLM, TRI, TRP, TRW, UBS, VLO, VSH, WM, X, YNDX Comment! [Earnings]
- Monday, October 29, 2012, 5:30 PM Notable earnings before Tuesday’s open: ADM, AGCO, AGN, ALLT, AMTD, ASH, BP, CAH, CBB, CIE, CMI, DB, DLPH, ECL, F, GNV, GOV, HCP, HE, IPGP, IPXL, JCI, LLL, MCGC, MPW, NUS, PCS, PNR, SWC, TLM, TRI, TRP, TRW, UBS, VLO, VSH, WM, X, YNDX Comment! [Earnings]
- Thursday, October 4, 2012, 2:28 PM The publication of results from a recent study in the New England Journal of Medicine using Allergan's (AGN +0.5%) Botox as a treatment for overactive bladder in women looks to be a positive. Results showed that a single injection of Botox into a woman’s bladder reduces urinary incontinence as effectively as daily drugs and is actually better at resolving the problem. This opens up a new market for the drug as a first line of defense for women who struggle with frequent urinary leakage, and if approved, could generate as much as $216M in sales by 2015. Comment! [Healthcare]
- Wednesday, September 26, 2012, 7:56 AM The EU proposes tougher standards on medical devices and implants after investigations showed hundreds of thousands of women were at risk from substandard silicone implants. Independent assessment of manufacturers and increased product testing could result from the new legislation. 4 Comments [Healthcare]
- Thursday, August 23, 2012, 2:19 PM Akorn (AKRX -0.4%) has reportedly received FDA approval for its generic version of of Allergan's (AGN) Alocril, a prescription eye drop for itchy allergy eyes. Comment! [Healthcare]
- Tuesday, August 21, 2012, 10:29 AM Allergan (AGN +0.5%) and Molecular Partners have entered into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases, with a specific emphasis on age-related macular degeneration. Comment! [Healthcare]
- Wednesday, August 1, 2012, 10:04 AM Allergan (AGN) declares $0.05/share quarterly dividend, in line with previous. Forward yield 0.23%. For shareholders of record Aug 23. Payable Sep 13. Ex-div date Aug 21. (PR) Comment! [Dividends]
- Wednesday, August 1, 2012, 9:50 AM More on Allergan (AGN +7.9%) Q2: net profit rises to $296M from $249M. Sales breakdown: specialty pharmaceuticals +5% and 8.8% on a constant currency basis; medical devices +4% and +8.3%. Guidance: FY EPS $4.15-$4.19 vs. consensus of $4.17, revenue of $4.74B-$4.85B vs. $5.85B. Q3: EPS of $1.02-$1.04 vs. $1.06, revenue of $1.37B-$1.445B vs. $1.44B. Comment! [Earnings, Healthcare, On the Move]
- Wednesday, August 1, 2012, 9:20 AM Allergan (AGN): Q2 EPS of $1.07 beats by $0.01. Revenue of $1.47B (+6.5% Y/Y) misses by $30M. Shares +2.3% premarket. (PR) Comment! [Earnings, Healthcare, On the Move]
- Wednesday, August 1, 2012, 12:05 AM Notable earnings before Wednesday’s open: ADP, AGN, AMT, AVP, CMCSA, D, DVN, EPD, EXC, HUN, MA, MFA, MRO, OC, RRD, SHPG, TLM, TWX Comment! [Earnings]
- Tuesday, July 31, 2012, 5:30 PM Notable earnings before Wednesday’s open: ADP, AGN, AMT, AVP, CMCSA, D, DVN, EPD, EXC, HUN, MA, MFA, MRO, OC, RRD, SHPG, TLM, TWX Comment! [Earnings]
- Monday, July 9, 2012, 12:54 PM Allergan (AGN -1.8%) stumbles midday as RBC says Caremark has removed Lumigan from its 2013 formulary coverage. RBC sees a $0.15 hit to AGN's 2013 EPS (company earned $0.74 in 2012 Q1). Comment! [Healthcare, Quick Ideas]
-
O. Young Kwon
TANER Stock Model [TSM] Momentum 10/19/2012 (Friday): (1-2) Allergan (AGN) Mosaic (MOS) Nu Skin (NUS) <c> - View all 2 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
- View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c> -
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c> -
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c> -
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c> -
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c> -
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c> -
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c> -
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
LATEST REPLIES
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c> -
O. Young Kwon: The letters in the parentheses are ticker symbols which are in the Daily TANER Momentum [DTM] (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c> -
O. Young Kwon: The letters in the parentheses are ticker symbols which are in the Daily TANER Momentum [DTM] (my Instablog) with their security names. yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (9/24/2012, Monday) Numbers = Term in months. The TANER Stock Model [TSM} was introduced in my <c> -
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (9/13/2012, Thursday) Numbers = Term in months. The TANER Stock Model [TSM} was introduced in my <c> -
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly yk
-
Michael Bryant
"Cramer thinks Allergan (AGN) and Starbucks (SBUX) represent two terrific" buys. Go with SBUX. http://yhoo.it/U8fPyL - View all 1 replies
-
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (9/11/2012, Tuesday) Numbers = Term in months. The TANER Stock Model [TSM} was introduced in my <c> -
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (8/27/2012, Monday) 1,2,3 = 1-m, 2-m, 3-month term. <c> -
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (8/24/2012, Friday) 1,2,3 = 1-m, 2-m, 3-month term. <c> -
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (8/20/2012, Monday) 1,2,3 = 1-m, 2-m, 3-month term. <c> -
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (8/16/2012, Thursday) 1,2,3 = 1-m, 2-m, 3-month term. <c> -
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (8/10/2012, Friday) 1,2,3 = 1-m, 2-m, 3-month term. <c> -
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (8/8/2012, Wednesday) 1,2,3 = 1-m, 2-m, 3-month term. <c> -
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (8/8/2012, Wednesday) 1,2,3 = 1-m, 2-m, 3-month term. <c> -
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (8/7/2012, Tuesday) 1,2,3 = 1-m, 2-m, 3-month term. <c> -
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (8/2/2012, Thursday) 1,2,3 = 1-m, 2-m, 3-month term. <c> -
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
